72 related articles for article (PubMed ID: 77217)
21. [What is certain in therapy of prostatic adenoma and prostatic carcinoma?].
Klosterhalfen H
Internist (Berl); 1977 Dec; 18(12):642-9. PubMed ID: 74367
[No Abstract] [Full Text] [Related]
22. [Effect of bromocriptine on prolactin secretion after dopaminergic receptor blockade with metoclopramide in patients with prostatic cancer treated with estrogens].
Baranowska B; Szymanowski J; Jeske W
Endokrynol Pol; 1984; 35(4):211-7. PubMed ID: 6510364
[No Abstract] [Full Text] [Related]
23. Circadian aspects of serum prolactin and TSH lowering by bromocriptine in patients with prostatic hypertrophy.
Tarquini B; Halberg F; Seal US; Benvenuti M; Cagnoni M
Prostate; 1981; 2(3):269-79. PubMed ID: 6170968
[TBL] [Abstract][Full Text] [Related]
24. [Value of palliative treatment of metastasizing prostatic cancer with the prolactin inhibitor parlodel].
Ausfeld R; Huber P; Del Pozo E
Helv Chir Acta; 1982 Aug; 49(3-4):459-62. PubMed ID: 6182128
[No Abstract] [Full Text] [Related]
25. Adjunct bromocriptine treatment as palliation for prostate cancer: experimental and clinical evaluation.
Jacobi GH; Altwein JE; Hohenfellner R
Scand J Urol Nephrol Suppl; 1980; 55():107-12. PubMed ID: 6163204
[TBL] [Abstract][Full Text] [Related]
26. [Relation of prolactin with nodular hyperplasia and carcinoma of the prostate].
Romero L; Muñoz C; López A; Vilches J
Actas Urol Esp; 1991; 15(6):503-9. PubMed ID: 1724345
[TBL] [Abstract][Full Text] [Related]
27. [The treatment of pseudopregnancy in the bitch with prolactin inhibitors metergoline and bromocriptine].
Grünau B; Nolte I; Hoppen HO
Tierarztl Prax; 1996 Apr; 24(2):149-55. PubMed ID: 8650684
[TBL] [Abstract][Full Text] [Related]
28. [Antitumor effect of bromocriptine in 5 cases of invasive prolactinoma].
Guibout M; Jaquet P; Grisoli F; Tapias PL; Mouly A
Ann Med Interne (Paris); 1982; 133(1):48-50. PubMed ID: 7065589
[No Abstract] [Full Text] [Related]
29. Use of bromocriptine as a diagnostic and therapeutic tool in hyperprolactinemic states.
Abraham G
Prog Clin Biol Res; 1982; 112 Pt A():255-73. PubMed ID: 7163300
[No Abstract] [Full Text] [Related]
30. [From the determination of prolactin to use of its inhibitor: bromocriptine].
Schaison G; Georges D; Coustenoble J
Sem Hop; 1978 Feb; 54(4):218-9. PubMed ID: 208171
[No Abstract] [Full Text] [Related]
31. Bromocriptine.
McGregor AM
Practitioner; 1981 Oct; 225(1360):1471-5. PubMed ID: 7329935
[No Abstract] [Full Text] [Related]
32. Prolactinoma and bromocriptine therapy.
Skaf RA
N J Med; 1986 Jul; 83(7):455-60. PubMed ID: 3528940
[No Abstract] [Full Text] [Related]
33. [Treatment of prostatic carcinoma with local injection of dithizone].
Ishibe T; Fukushige M; Tanaka H; Mizoguchi M; Fujimoto Y
Hinyokika Kiyo; 1968 Dec; 14(12):886-95. PubMed ID: 4180160
[No Abstract] [Full Text] [Related]
34. Effect of bromocriptine on seminal vesicular and prostatic metabolism in the immature bonnet monkey Macaca radiata Geoffroy.
Arunakaran J; Aruldhas MM; Govindarajulu P
Indian J Exp Biol; 1985 Dec; 23(12):679-81. PubMed ID: 3833685
[No Abstract] [Full Text] [Related]
35. [Botulinic toxin of type A in the treatment of prostatic adenoma and cancer].
Mazo EB; Krivoborodov GG; Shkol'nikov ME; Efremov NS
Urologiia; 2008; (4):63-6. PubMed ID: 19058365
[No Abstract] [Full Text] [Related]
36. [Hormone therapy for prostatic carcinoma and hypertrophy].
Hanschke HJ
Dtsch Med Wochenschr; 1969 Mar; 94(13):677-8. PubMed ID: 4180637
[No Abstract] [Full Text] [Related]
37. Estrogens in carcinoma of the prostate. Effects on enzymes and polypeptide hormones.
Dunzendorfer U; Drahovsky D
Arzneimittelforschung; 1978; 28(6):1027-30. PubMed ID: 86358
[TBL] [Abstract][Full Text] [Related]
38. Antiandrogens and prostatic tumours (experimental base and clinical use).
Neumann R; Schenck B; Senge T; Richter KD
Prog Clin Biol Res; 1976; 6():169-88. PubMed ID: 66688
[No Abstract] [Full Text] [Related]
39. The pharmacological action of bromocriptine on the human prostate.
Shapiro A; Ron M; Caine M; Kramer J
Urol Res; 1980; 8(1):25-8. PubMed ID: 6154367
[No Abstract] [Full Text] [Related]
40. Human benign prostatic hypertrophy: role of prostaglandin E2 and its relationships to bromocriptine therapy.
Rolland PH; Martin PM; Serment G; Roulier R; Rolland AM
Eur Urol; 1981; 7(1):41-5. PubMed ID: 6161821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
